Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Pediatric Oncology
Cardiotoxicity
Questions discussed in this category
How would you manage metastatic alveolar soft part sarcoma in an young patient failing TKI?
How do you incorporate PD-L1 blockade?
1 Answer available
10360
Papers discussed in this category
The Lancet. Oncology, 2019-06
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Related Topics in Pediatric Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers